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Objective: To analyze the radiological spectrum of HRCT in COVID-19 patients, clinically symptomatic but 
initially having negative RT-PCR. 
Study Design: Prospective cross-sectional descriptive study. 
Place and Duration of Study: Radiology and Medicine Department, DHQ Hospital Rawalpindi, from June to 
November 2020 
Materials and Methods: The study included 90 patients presenting with clinical symptoms of COVID-19 but with 
negative RT-PCR. All patients underwent chest computed tomography (CT). Patients having non-COVID-19 
HRCT features with negative RT-PCR were excluded from the study. 
Results: Out of 90 symptomatic, RT-PCR negative patients, 7 had normal chest CT. According to BSTI 
classification, 50 patients showed classic, 11 had probable and 22 had indeterminate features. Unilateral changes 
were in 8 (8.9%) and bilateral in 75 (83.3%). The most common finding was a mixed pattern of peripherally 
distributed GGN and bronchocentric nodules in 37 (41.1%) patients. Consolidations were in 19 (21.1%), pure 
ground-glass haze in 13 (14.4%), crazy paving in 4 (4.4%), fuzzy bands and arcades in 7 (7.8%), and subtle 
gravitational GGH in 3 (3.3%) patients. CT-SS classified 69 (76.7%) patients as mild, 10 (11.1%) as moderate and 4 
(4.4%) as severe disease. 
Conclusions: HRCT with CTSS is an important tool for diagnosing and prognosticating COVID-19 infection 
despite negative RT-PCR, timely identifying and isolating COVID-19 cohorts preventing cross-infection and also 
aiding in prompt symptomatic management. 
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Introduction 
 
Coronavirus pandemic has caused turmoil all over the 
world causing disastrous effects worldwide. COVID-
19 has various clinical presentations and radiologically 
it has a typical appearance according to which it could 
be classified as classic, probable, intermediate and 
Non-COVID-19.1 Despite efforts from national disaster 
management to provide faster and accurate RT-PCR 
testing, the literature suggests the sensitivity of 
diagnosis of COVID-19 infection by RT-PCR assays is 
60% and by HRCT 93%.2 Performing CT for sick 
patients with negative COVID-19 RT-PCR became 
essential to triage patients to the COVID-19 unit. A 
standard protocol was decided to perform CT of only 
those patients who had negative RT-PCR test and 
utilizing the use of CT in the rapid triage for effective 
timely identification of COVID-19 cohorts. It also 
meant that if CT is typical, the RT-PCR test will need 
to be repeated, thus preventing clinicians to discharge 
patients labelling them as COVID-19 negative.  The 
rationale of our study is to recognize the typical and 
classic features of COVID-19 on HRCT despite 
negative RT-PCR assay so these patients could be 
isolated timely to prevent cross-infection and also to 
assess CT severity score (CT-SS) in categorizing the 
disease into mild, moderate and severe so they can be 
managed accordingly. The study is an effort to analyze 
the radiological spectrum of HRCT in COVID-19 
patients, clinically symptomatic but initially having 
negative RT-PCR 
 
Materials and Methods 
 
A prospective descriptive study was conducted after 
approval from institutional review board Rawalpindi 
Medical University, on 90 patients selected by non-
probability convenient sampling, from June to 
November 2020, in Radiology and Medicine 
Department, District Head Quarters Hospital 
Rawalpindi who had presented with classical clinical 
symptoms of COVID-19 infection but their polymerase 
chain reaction (PCR) for COVID-19 was negative. All 
these patients underwent high resolution computed 
tomography (HRCT) of the chest by Toshiba Aquilion 
16 slice CT scanner with 120 kVp, 100 to 200 mAs, 350 
mm FOV and a slice thickness of 0.6-1.25 mm. For each 
patient HRCT was evaluated for features of COVID-19 
ground-glass haze, consolidation, crazy paving, 
nodules, cavitations, effusions, axial or peripheral 
distribution of lesions, lobes involved) and then these 
patients were classified according to the British Society 
of Thoracic Imaging (BSTI) Classification of COVID-19 
as Classic COVID-19 (100% confidence for COVID-19) 
if there was lower lobe predominant, peripheral, 
multiple, bilateral foci of ground glass haze ± Crazy-
paving, peripheral consolidation with or without air 
bronchograms or reverse halo/ perilobular pattern. 
They were classified as Probable COVID-19 (71-99% 
confidence for COVID-19) if lower lobe predominant, 
the mix of bronchocentric and peripheral 
consolidation, reverse halo/ perilobular pattern and 
GGO scarce was observed. If the clinical context is 
wrong or suggests an alternative diagnosis (e.g. an 
interstitial lung disease in a connective tissue disease 
setting) or HRCT showing lobar pneumonia, cavitating 
infections, tree-in bud/ centrilobular nodules, 
lymphadenopathy, effusions, established pulmonary 
fibrosis, then the patient was labelled as non-COVID-
19 and was excluded from the study. If the patient did 
not fit into the classic or probable or non-COVID-19 
category, then they were classified as indeterminate 
COVID-19 (< 70% confidence for COVID-19). A repeat 
PCR test or serology was sent of all these patients for 
laboratory confirmation of infection with Covid-19. 1 A 
CT severity score (CT-SS) of all these patients was also 
calculated by adding up individual scores from 20 
regions of both lungs based on the extent of 
involvement of each of these lung regions, score 
assigned 0, 1, or 2 respectively if 0%, less than 50% or 
more than 50% involvement, score ranging from 0-40.3 
All patients were followed up after 6 weeks for any 
residual symptoms. Age, co-morbids, symptoms were 
analyzed as frequencies and percentages. HRCT 
findings were categorized according to BSTI 
classification and a CT-SS was assigned. The data was 
collected with the help of a proforma and was 




A total of 90 cohorts, 35 (38.9%) were females and 55 
(61.1%) were males. The mean age of patients was 
calculated to be 45.06 (range 23-95 years). Most of the 
patients that is 57 (63.3%) presented with mixed 
symptomology of cough, shortness of breath, body 
aches, GI disturbances or altered consciousness with or 
without fever. Fever was the only presenting 
complaint in 13 (14.4%) patients, shortness of breath 
was the only symptom in 7 (7.8%) patients, 9 (10%) 
patients presented with a cough only, 2 (2.2%) patients 
complained of body aches, 1(1.1%) patient presented 
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with chest tightness and 1 (1.1%) patient presented 
with diarrhoea.  
Out of these 90 symptomatic and RT-PCR negative 
patients, 7 had normal chest CT but they underwent a 
repeat RT-PCR test due to strong clinical suspicion and 
all of them were confirmed as COVID-19 infected on 
subsequent RT- PCR test. HRCT of 50 patients showed 
classic BSTI COVID-19 features. 11 patients had 
probable BSTI COVID-19. Indeterminate BSTI features 
were seen in 22 patients. Unilateral lung parenchymal 
involvement was seen in 8 (8.9%) patients in contrast 
to 75 (83.3%) patients who had bilateral involvement. 
A mixed pattern of multilobular, peripherally located, 
bronchocentric ground-glass nodules (Figure 1a), 
bands or nodular consolidates (Figure 1b) was seen in 
37 (41.1%) patients, 19 (21.1%) patients developed 
consolidations as predominant finding, 13 (14.4%) 
patients showed peripherally distributed pure ground-
glass haze only. Crazy paving (Figure 1c) was seen in 4 
(4.4%) patients. Fuzzy arcades and subpleural bands 
(Figure 2a) were observed in 7 (7.8%) patients and 3 
(3.3%) patients showed indeterminate features of 
subtle ground-glass haze in gravitational distribution 
with classical vascular prominence. Vascular 
prominence was seen in relation to lung parenchymal 
abnormality almost in all patients (Figure 3a). In 
addition to these features, we also observed 
bronchioloectasis along with ground glass haze 
(Figure 2b and 2c) in 7 patients. 2 patients had pre-
existing interstitial disease and 2 patients had previous 
changes of tuberculosis infection. We had only 1 case 
with a reverse halo sign (Figure 3b). 2 patients 
developed pleural effusion. None of the patients 
showed enlarged lymph nodes but sub centimetre 
mediastinal lymph nodes were seen in all the patients. 
Results are summarized in Table 1. 
 
Table 1: Characteristics of COVID-19 on High-Resolution CT Chest 
CHARACTERISTIC NO. OF PATIENTS (N=90) 




Gender Male 35 (38.9%) 
Female 55 (61.1%) 
Symptoms Mixed symptoms 57 (63.3%) 
Fever only 13 (14.4%) 
Shortness of breath only 7 (7.8%) 
Cough only 9 (10%) 
Body aches only 2 (2.2%) 
Chest tightness only 1 (1.1%) 
Diarrhea only 1 (1.1%) 
Imaging Characteristics 
Laterality Normal 7 (7.8%) 
Bilateral 75 (83.3%) 
Unilateral 8 (8.9%) 
Lung Parenchymal Pattern 
According to BSTI 
Normal 7 (7.8%) 
Classic 50 (55.6%) 
Probable 11 (12.2%) 
Indeterminate 22 (24.4%) 
Lung parenchymal Patterns Normal 7 (7.8%) 
Mixed GGN and consolidates 37 (41.1%) 
Pure Consolidations 19 (21.1%) 
Pure Ground glass haze 13 (14.4%) 
Fuzzy Bands 7 (7.8%) 
GGH with crazy paving 4 (4.4%) 
Gravitational ground-glass haze 3 (3.3%) 
 
 
Additional Imaging Features 
Vascular Prominence 83 (92.2%) 
Bronchioloectasis 7 (7.8%) 
Reverse halo 1 (1.1%) 
Pre existing ILD 2 (2.2%) 
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Pre-existing Tuberculosis 2 (2.2%) 
Pleural effusion 2 (2.2%) 
Lymphadenopathy 0 




Normal       7 (7.8%) 7 0 0 
Mild           69 (76.7%) 62  7 0 
Moderate   10 (11.1%) 5 4 1 
Severe        4 (4.4%) 0 2 2 
 
 
Figure 1a: Subtle bronchocentric ground-glass 
nodules (arrow) 
 
Figure 1b: Bronchocentric ground glass nodules and 
nodular consolidates (arrows) 
 













Figure 2c: Sub pleural patches of ground glass haze 
and bronchioloectasis (arrows) 
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Figure 3b: Subtle haze peripherally and gravitational 
distribution with reverse halo (arrows) 
 
All these patients initially RT-PCR negative, diagnosed 
as COVID-19 by HRCT were then retested for 
laboratory diagnosis, and there were 17 (18.89%) 
patients who had persistent negative RT-PCR tests on 
subsequent testing, despite supportive CT features and 
classic clinical features. The rest of the patients on 
subsequent testing either showed positive antibody 
titre or 1st or 2nd subsequent positive RT-PCR. 
 We also categorized patients according to CT severity 
score and followed them up after 4 weeks. We 
observed 69 (76.7%) patients had mild having CT 
severity score up to 20/40, 2 of them died, 5 had mild 
residual cough and breathlessness and the rest of them 
recovered uneventfully on follow up. Ten (11.1%) 
patients had moderate disease, having CTSS from 21 
to 30/40 and amongst them, 4 had mild residual 
shortness of breath and 1 of them died. Four (4.4%) 
patients had severe disease having CTSS more than 
30/40, amongst them 2 died, and 2 had severe oxygen-




Figure 4: Disease severity and patient prognosis 




The current study showed 17 (18.9%) patients having 
false negative RT-PCR with findings on HRCT. Recent 
various studies suggest relatively low efficiency of RT-
PCR as compared to HRCT. Inadequate or 
inappropriate sampling, low viral load in patients or 
viral mutations are few reasons contributing to the low 
efficiency of PCR test. Fang et al reported higher 
sensitivity of chest CT (98%) as compared to RT-PCR 
(71%).4 Ai et al reported that 97% of RT-PCR positive 
patients show positive findings on the chest. 2 A study 
by Italian researchers evaluated 158 patients and 
found HRCT to be 97% sensitive.5 Similarly Dangis et 
al conducted a study in Belgium and found the 
sensitivity of CT to be around 87%.6 In RT-PCR 
negative patients HRCT is a rapid and reliable 
diagnostic modality to identify and quarantine Covid-
19 cohorts compared to serological tests which are 
more accurate if samples are assessed 20 days after the 
first symptom.7 In Pakistan we also experienced 
numerous symptomatic patients with repetitive 
negative RT-PCR which posed a clinical concern not 
just regarding their clinical treatment but also triaging 
them to Covid-19 isolations and quarantine. Various 
international imaging societies including the American 
College of Radiology, the British Society of Thoracic 
Imaging, the Fleischner Society and others, 
recommend the use of CT not only to evaluate and 
prognosticate RT-PCR confirmed Covid-19 patients 
but also to diagnose patients of COVID disease.8,9,10 
Radiology society of Pakistan also fully endorsed 
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international societies and proposed CT as a diagnostic 
tool for COVID-19.11   
In our study, we also evaluated different spectrums of 
COVID-19 infection. We observed a mixed pattern of 
peripherally distributed ground-glass nodules (GGN) 
and bronchocentric nodules was the most common 
parenchymal feature, seen in 41.1% of patients. 
Patients showing GGN were those who presented 
early in the course of the disease and these patients 
also showed relatively lower CT-SS. Consolidations 
were seen as a predominant finding in 21.1% of 
patients and these patients were those who presented 
late with higher severity scores. 14.4% of patients had 
pure classical GGH. This is comparable to a recent 
study by Parry et al which demonstrated a mixed 
pattern in 41.2%, and pure GGH in 29%.12 A local 
study by Khaliq et al, found a predominant ground-
glass pattern in 88% and predominant consolidations 
in 52% of patients.13 A study by Zhou et al showed 
reverse halo in 4% of patients whereas we just had 1.1 
%.14 Patients with unilateral lung involvement were 
seen less frequently in our study, only in 8.9% of cases 
as compared to 83.3 % of cases bilaterally and previous 
studies also supported that bilateral involvement is 
more common.12, 13 
There were a few limitations in our study. Firstly the 
study was conducted in a public sector hospital of a 
developing country and a dedicated CT machine was 
not available for COVID-19 patients hence a standard 
protocol was followed to evaluate only those patients 
on CT who were clinical COVID-19 suspects with 
negative RT-PCR and needed a diagnosis. This not 
only created a selection bias but also CT features of 
RT-PCR negative patients was not compared with RT-
PCR positive patients. Secondly, our sample size was 
also small as our study required subsequent 
serological or PCR confirmation and some patients 
were lost to follow up. Thirdly we didn’t compare and 
correlated CT features and CT-SS with inflammatory 




It is concluded that CT has typical features of COVID-
19 on HRCT and it is an important tool for diagnosing 
COVID-19 infection despite negative COVID-19 RT-
PCR assay so these patients could be isolated timely to 
prevent cross-infection. Furthermore, CT severity 
score (CT-SS) helps in prognosticating patients and 
categorises disease into mild, moderate and severe, 
aiding clinicians for appropriate treatment. 
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